Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis

by Neil A. Zakai, Rob F. Walker, Richard F. MacLehose, Insu Koh, Alvaro Alonso, Pamela L. Lutsey
Published 2021-08-01

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding

by Richard F. MacLehose, Neil A. Zakai, Rob F. Walker, Alvaro Alonso, Terrence Adams, Pamela L. Lutsey
Published 2021-05-01

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017

by Pamela L. Lutsey, Rob F. Walker, Richard F. MacLehose, Alvaro Alonso, Terrence J. Adam, Neil A. Zakai
Published 2019-10-01

Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism

by Alvaro Alonso, Faye L. Norby, Richard F. MacLehose, Neil A. Zakai, Rob F. Walker, Terrence J. Adam, Pamela L. Lutsey
Published 2021-09-01

Effect of Chronic Digoxin Use on Mortality and Heart Failure Hospitalization in Pulmonary Arterial Hypertension

by Kevin Y. Chang, Katherine Giorgio, Katlin Schmitz, Rob F. Walker, Kurt W. Prins, Marc R. Pritzker, Stephen L. Archer, Pamela L. Lutsey, Thenappan Thenappan
Published 2023-03-01

Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database

by Pamela L. Lutsey, Line H. Evensen, Thenappan Thenappan, Kurt W. Prins, Rob F. Walker, Joel F. Farley, Richard F. MacLehose, Alvaro Alonso, Neil A. Zakai
Published 2022-07-01